🇺🇸 FDA
Patent

US 10668049

Methods of treating cognitive decline with transforming growth factor beta inhibitors

granted A61KA61K31/00A61K31/4178

Quick answer

US patent 10668049 (Methods of treating cognitive decline with transforming growth factor beta inhibitors) held by The Regents of the University of California expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/00, A61K31/4178, A61K31/4439, A61K31/70